633 related articles for article (PubMed ID: 27009953)
41. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
[TBL] [Abstract][Full Text] [Related]
42. Regulation of EBNA1 protein stability and DNA replication activity by PLOD1 lysine hydroxylase.
Dheekollu J; Wiedmer A; Soldan SS; Castro-Muñoz LJ; Chen C; Tang HY; Speicher DW; Lieberman PM
PLoS Pathog; 2023 Jun; 19(6):e1010478. PubMed ID: 37262099
[TBL] [Abstract][Full Text] [Related]
43. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).
Lu F; Wikramasinghe P; Norseen J; Tsai K; Wang P; Showe L; Davuluri RV; Lieberman PM
Virol J; 2010 Oct; 7():262. PubMed ID: 20929547
[TBL] [Abstract][Full Text] [Related]
44. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.
Sarkari F; Sanchez-Alcaraz T; Wang S; Holowaty MN; Sheng Y; Frappier L
PLoS Pathog; 2009 Oct; 5(10):e1000624. PubMed ID: 19834552
[TBL] [Abstract][Full Text] [Related]
45. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
46. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.
Chen YL; Liu CD; Cheng CP; Zhao B; Hsu HJ; Shen CL; Chiu SJ; Kieff E; Peng CW
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):243-8. PubMed ID: 24344309
[TBL] [Abstract][Full Text] [Related]
47. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
[TBL] [Abstract][Full Text] [Related]
48. The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus.
Dheekollu J; Lieberman PM
J Virol; 2011 Jun; 85(12):5853-63. PubMed ID: 21490103
[TBL] [Abstract][Full Text] [Related]
49. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.
Li H; Minarovits J
Adv Cancer Res; 2003; 89():133-56. PubMed ID: 14587872
[TBL] [Abstract][Full Text] [Related]
50. Regulation of Epstein-Barr virus origin of plasmid replication (OriP) by the S-phase checkpoint kinase Chk2.
Zhou J; Deng Z; Norseen J; Lieberman PM
J Virol; 2010 May; 84(10):4979-87. PubMed ID: 20200249
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.
Murata T; Kondo Y; Sugimoto A; Kawashima D; Saito S; Isomura H; Kanda T; Tsurumi T
J Virol; 2012 May; 86(9):4752-61. PubMed ID: 22357272
[TBL] [Abstract][Full Text] [Related]
52. The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus.
Deutsch MJ; Ott E; Papior P; Schepers A
J Virol; 2010 Mar; 84(5):2533-46. PubMed ID: 20032186
[TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr virus episome stability is coupled to a delay in replication timing.
Zhou J; Snyder AR; Lieberman PM
J Virol; 2009 Mar; 83(5):2154-62. PubMed ID: 19073720
[TBL] [Abstract][Full Text] [Related]
54. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
55. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
[TBL] [Abstract][Full Text] [Related]
56. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
Paulson EJ; Fingeroth JD; Yates JL; Speck SH
Virology; 2002 Jul; 299(1):109-21. PubMed ID: 12167346
[TBL] [Abstract][Full Text] [Related]
57. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
58. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes.
Sears J; Ujihara M; Wong S; Ott C; Middeldorp J; Aiyar A
J Virol; 2004 Nov; 78(21):11487-505. PubMed ID: 15479791
[TBL] [Abstract][Full Text] [Related]
59. Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.
Hsieh DJ; Camiolo SM; Yates JL
EMBO J; 1993 Dec; 12(13):4933-44. PubMed ID: 8262037
[TBL] [Abstract][Full Text] [Related]
60. The linking regions of EBNA1 are essential for its support of replication and transcription.
Mackey D; Sugden B
Mol Cell Biol; 1999 May; 19(5):3349-59. PubMed ID: 10207059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
